Several reports have indicated that the infiltration of CD1a-positive (CD1a+) DCs into tumor tissue is associated with favorable clinical outcomes in carcinomas of the ovary [13], oral cavity [14, 15], thyroid [16] and gallbladder [17]. The gene discussed is CD1A; the disease is neoplasm.